BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12015268)

  • 21. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS.
    Vorce SP; Holler JM; Levine B; Past MR
    J Anal Toxicol; 2008; 32(6):444-50. PubMed ID: 18652752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry.
    Staack RF; Fehn J; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(1):27-41. PubMed ID: 12726841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry.
    Peters FT; Meyer MR; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):81-91. PubMed ID: 16046201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-beta- phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1509-19. PubMed ID: 17103384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New designer drug, 2,5-dimethoxy-4-propylthio-beta-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry.
    Theobald DS; Fehn S; Maurer HH
    J Mass Spectrom; 2005 Jan; 40(1):105-16. PubMed ID: 15643651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-alpha-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry.
    Springer D; Peters FT; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jun; 773(1):25-33. PubMed ID: 12015267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry.
    Springer D; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):253-66. PubMed ID: 14581066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-beta-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques.
    Theobald DS; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 842(2):76-90. PubMed ID: 16600701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry.
    Staack RF; Theobald DS; Maurer HH
    Ther Drug Monit; 2004 Aug; 26(4):441-9. PubMed ID: 15257075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.
    de Boer D; Bosman IJ; Hidvégi E; Manzoni C; Benkö AA; dos Reys LJ; Maes RA
    Forensic Sci Int; 2001 Sep; 121(1-2):47-56. PubMed ID: 11516887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.
    Ewald AH; Ehlers D; Maurer HH
    Anal Bioanal Chem; 2008 Apr; 390(7):1837-42. PubMed ID: 18259731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.
    Ensslin HK; Kovar KA; Maurer HH
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):189-97. PubMed ID: 8891915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vivo and in vitro metabolism and the detectability in urine of 3',4'-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MS(n.).
    Meyer MR; Mauer S; Meyer GM; Dinger J; Klein B; Westphal F; Maurer HH
    Drug Test Anal; 2014; 6(7-8):746-56. PubMed ID: 24124065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lefetamine-derived designer drugs N-ethyl-1,2-diphenylethylamine (NEDPA) and N-iso-propyl-1,2-diphenylethylamine (NPDPA): metabolism and detectability in rat urine using GC-MS, LC-MSn and LC-HR-MS/MS.
    Wink CS; Meyer GM; Wissenbach DK; Jacobsen-Bauer A; Meyer MR; Maurer HH
    Drug Test Anal; 2014 Oct; 6(10):1038-48. PubMed ID: 24591097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry.
    Springer D; Fritschi G; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 793(2):331-42. PubMed ID: 12906908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry.
    Meyer MR; Wilhelm J; Peters FT; Maurer HH
    Anal Bioanal Chem; 2010 Jun; 397(3):1225-33. PubMed ID: 20333362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.
    Peters FT; Schaefer S; Staack RF; Kraemer T; Maurer HH
    J Mass Spectrom; 2003 Jun; 38(6):659-76. PubMed ID: 12827635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) in toxicological analysis. Studies on the detection of clobenzorex and its metabolites within a systematic toxicological analysis procedure by GC-MS and by immunoassay and studies on the detection of alpha- and beta-amanitin in urine by atmospheric pressure ionization electrospray LC-MS.
    Maurer HH; Kraemer T; Ledvinka O; Schmitt CJ; Weber AA
    J Chromatogr B Biomed Sci Appl; 1997 Feb; 689(1):81-9. PubMed ID: 9061484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.